June 21, 2021
Learn More
July 18, 2022
Understanding Project Optimus
The FDA’s Oncology Center of Excellence has launched an initiative to reform the dose optimization and dose selection paradigm in oncology drug development. Known as Project Optimus, this initiative recommends a core change in how doses are selected during oncology clinical trials and post-approval studies.
Sirj Goswami, PhD, CEO, co-founder of InsightRX and Jason Rizzo, MBA, VP Global Biopharma Strategy discuss this topic in more detail in an article published by Applied Clinical Trials*.
Click here to read the full article. Read Full Article
Filter By:
Apply Filters
Category
April 04, 2023
Learn More
InsightRX Presents Research Evaluating Effectiveness of Model-Informed Precision Dosing for Heparin at Annual Anticoagulation Forum Meeting
March 14, 2023
Learn More
InsightRX Continues Accelerated Growth with Life Sciences Organizations and Health Systems
March 08, 2023
Learn More
Evaluating and Improving Neonatal Gentamicin Pharmacokinetic Models Using Aggregated Routine Clinical Care Data
March 08, 2023
Learn More
Prospective Validation and Refinement of a Population Pharmacokinetic Model of Fludarabine in Children and Young Adults Undergoing Hematopoietic Cell Transplantation
March 08, 2023
Learn More
Evaluation of Neonatal and Paediatric Vancomycin Pharmacokinetic Models and the Impact of Maturation and Serum Creatinine Covariates in a Large Multicentre Data Set
February 28, 2023
Learn More
Scrip Asks…What Does 2023 Hold for Biopharma? Part 5: Technological Advances
January 03, 2023
Learn More
The 2023 PharmaVoice Crystal Ball: Peering into the future of life sciences
December 16, 2022
Learn More
What to Expect from AI-Enabled Drug Discovery in 2023
December 13, 2022
Learn More
InsightRX Provides Máxima Medical Center with Precision Dosing Guidance
December 01, 2022
Learn More
InsightRX to Showcase Precision Dosing Technology at ASHP 2022 Midyear Meeting
November 21, 2022
Learn More
Clinical Decision Support for Precision Dosing: Opportunities for Enhanced Equity and Inclusion in Health Care
October 19, 2022
Learn More
InsightRX to Showcase New Advances in Precision Dosing Technology during IDWeek 2022
October 11, 2022
Learn More
InsightRX Offers Precision Dosing Support for New Drug Categories
September 07, 2022
Learn More
The Evolution of Therapeutic Drug Monitoring for Tacrolimus
August 09, 2022
Learn More
Healix and InsightRX Provide Patient-Specific Precision Dosing for Outpatient Infusion Therapy
July 25, 2022
Learn More
InsightRX Precision Medicine Software Platform Selected by Amsterdam UMC 
July 18, 2022
Learn More
Understanding Project Optimus
June 01, 2022
Learn More
InsightRX Helps Boone County Hospital Improve Patient Safety with Precision Dosing
April 06, 2022
Learn More
Understanding FDA’s Perspective On Precision Dosing
April 05, 2022
Learn More
Roadmap Preview: Biomarker-Guided And Pharmacogenomic-Informed Dosing
March 28, 2022
Learn More
InsightRX Reports Record Growth In Platform Adoption By Health Systems And Biopharma Companies
March 27, 2022
Learn More
Population Pharmacokinetic Model Development of Tacrolimus in Pediatric and Young Adult Patients Undergoing Hematopoietic Cell Transplantation
March 25, 2022
Learn More
Model-Based Tacrolimus Follow-Up Dosing in Adult Renal Transplant Recipients: A Simulation Trial.
March 24, 2022
Learn More
Roadmap Preview: Bringing Precision Dosing To New Therapeutic Areas
March 10, 2022
Learn More
Recent Product Enhancements
January 11, 2022
Learn More
The Role Of The Democratized Research Network In Optimizing Precision Dosing
December 21, 2021
Learn More
InsightRX Adds Renowned Pharmacology Experts Drs. Richard Peck And Michael Rybak To Its Scientific Advisory Board
December 20, 2021
Learn More
How Precision Drug-Dosing Supports Individualized Treatment
December 20, 2021
Learn More
Vancomycin And The Move To AUC-Based Dosing
December 20, 2021
Learn More
Using Precision Medicine To Prevent Adverse Drug Events
December 20, 2021
Learn More
It’s Time To Put An End To One-Size-Fits-All Drug Dosing
December 20, 2021
Learn More
9 Predictions For Pharma In 2022
December 15, 2021
Learn More
Making Medications Safer And More Effective Through Precision Dosing
December 15, 2021
Learn More
Dosages Can Be Tailored To Individuals For Safety And Efficacy
October 27, 2021
Learn More
How Precision Dosing Technology Helps Prevent Adverse Events
October 17, 2021
Learn More
Continuous Learning in Model-Informed Precision Dosing: A Case Study in Pediatric Dosing of Vancomycin
October 04, 2021
Learn More
InsightRX Selected For Inaugural Cohort In Cutting-Edge Innovation Hub To Transform Cancer Care
October 04, 2021
Learn More
InsightRX Selected For Inaugural Cohort In Cutting-Edge Innovation Hub To Transform Cancer Care
September 14, 2021
Learn More
Saladax Biomedical And InsightRX To Present Chemotherapy Drug Outcomes At International Congress In September
August 25, 2021
Learn More
InsightRX Receives CE Mark For Nova Software, Allowing It To Expand Precision Dosing Capabilities In Europe
August 13, 2021
Learn More
Hospital Precision Dosing Is Ramping Up
July 16, 2021
Learn More
A Hybrid Machine Learning/Pharmacokinetic Approach Outperforms Maximum a Posteriori Bayesian Estimation by Selectively Flattening Model Priors
June 07, 2021
Learn More
InsightRX’s Precision Medicine Platform Integrated Into Sentara Healthcare EHR To Help Safely Administer Vancomycin Doses For Treatment Of Infections
April 17, 2021
Learn More
Model-Based Estimation of Iohexol Plasma Clearance for Pragmatic Renal Function Determination in the Renal Transplantation Setting
March 30, 2021
Learn More
Population Pharmacokinetics and Genetics of Oral Meltdose Tacrolimus (Envarsus) in Stable Adult Liver Transplant Recipients
March 09, 2021
Learn More
Five Minutes In Healthcare – Featuring Sirj Goswami
March 01, 2021
Learn More
The Relationship Between Busulfan Exposure and Achievement of Sustained Donor Myeloid Chimerism in Patients with Non-Malignant Disorders
February 01, 2021
Learn More
Use of Age-Adjusted Serum Creatinine in a Vancomycin Pharmacokinetic Model Decreases Predictive Performance in Elderly Patients
August 18, 2020
Learn More
Mathematical model and tool to explore shorter multi-drug therapy options for active pulmonary tuberculosis
August 01, 2020
Learn More
The Pharmacokinetic and Pharmacodynamic Properties of Hydroxychloroquine and Dose Selection for COVID-19: Putting the Cart Before the Horse
July 30, 2020
Learn More
New Study Co-Authored By InsightRX Shows Model-Informed Precision Dosing Could Improve Efficacy Of Hematopoietic Cell Transplants While Reducing Toxicity
July 27, 2020
Learn More
Model-Informed Precision Dosing of Everolimus: External Validation in Adult Renal Transplant Recipients
July 08, 2020
Learn More
Pharmacy And Healthcare Professionals Nationwide Recognize Patient Safety Benefits Of New Consensus Vancomycin Dosing Guidelines, But Fewer Than One In Three Plan To Adopt Them
July 02, 2020
Learn More
Assessment of a Model-Informed Precision Dosing Platform Use in Routine Clinical Care for Personalized Busulfan Therapy in the Pediatric Hematopoietic Cell Transplantation (HCT) Population
June 05, 2020
Learn More
Prospective validation of a model-informed precision dosing tool for vancomycin in intensive care patients
April 30, 2020
Learn More
Get Real: Integration of Real-World Data to Improve Patient Care
April 29, 2020
Learn More
Model-Informed Precision Dosing of Vancomycin in Hospitalized Children: Implementation and Adoption at an Academic Children’s Hospital
April 13, 2020
Learn More
Simulated Comparison of a Bayesian Clinical Decision Support System Versus Standard of Care For Achieving Gentamicin Pharmacokinetic Targets in Neonates
March 20, 2020
Learn More
The Verdict is in: Why pharmacies should rapidly adopt new vancomycin dosing guidelines
February 03, 2020
Learn More
Bayesian Clinical Decision Support-guided Versus Clinician-guided Vancomycin Dosing in Attainment of Targeted Pharmacokinetic Parameters in a Paediatric Population
January 07, 2020
Learn More
InsightRX Named Finalist In Accenture’s HealthTech Innovation Challenge
November 13, 2019
Learn More
InsightRX And Premier Inc. Partner To Enable Hospitals, Health Systems And Providers To Individualize Treatment For Infectious Disease Patients
October 20, 2019
Learn More
InsightRX Presents At The American Conference On Pharmacometrics
September 24, 2019
Learn More
InsightRX CSO Presents At International Association Of Therapeutic Drug Monitoring And Clinical Toxicology
September 20, 2019
Learn More
Healthcare Technology Startup InsightRX Raises $10 Million To Enable Precision Dosing At Point Of Care
September 16, 2019
Learn More
Model-Based TDM In Oncology
June 01, 2019
Learn More
Personalized Tuberculosis Treatment Through Model-Informed Dosing of Rifampicin.
May 11, 2019
Learn More
Individualized Empiric Vancomycin Dosing in Neonates Using a Model-Based Approach
March 21, 2019
Learn More
InsightRX CEO Is A Panelist At 12th Annual Cooley Health Tech Conference
March 13, 2019
Learn More
InsightRX And Children’s Hospital Los Angeles (CHLA) To Partner On Precision Dosing
January 02, 2019
Learn More
InsightRX CEO To Speak At 2019 JPM Conference
December 07, 2018
Learn More
Model-Informed Precision Dosing at the Bedside: Scientific Challenges and Opportunities
November 13, 2018
Learn More
InsightRX CEO Is A Panelist At “AI Applied To Medicine – How Is It Impacting Us Today?”
September 24, 2018
Learn More
Pharmacometrics At The Bedside
September 21, 2018
Learn More
InsightRX Presents Its Vision For Precision Medicine At The HMS Momentum 2018 Conference
July 17, 2018
Learn More
The Right Dose: How Pharmacy Researchers Are Making Medicine More Precise
June 07, 2018
Learn More
InsightRX Wins The Platinum Award At Pulse@MassChallenge
May 26, 2018
Learn More
InsightRX Selected To Join PULSE@MassChallenge 2018 Program
May 26, 2018
Learn More
InsightRX Presents At The BIO Investor Forum
March 30, 2018
Learn More
Investing In The Future Of Healthcare With OSF Healthcare
March 30, 2018
Learn More
Stanford Children’s CMIO Talks Home-Grown Clinical Decision Support
November 03, 2016
Learn More
